Table S3 . " width="100%" height="100%">
Journal: Cell Reports
Article Title: A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
doi: 10.1016/j.celrep.2022.111903
Figure Lengend Snippet: Pseudoviral neutralization assays of BA.2.75 by vaccine and BA.1, BA.2, and BA.4/5 immune serum (A and B) IC50 values for the indicated viruses using serum obtained from vaccinees 28 days following their third dose of vaccine (A) Pfizer BNT162b2 (n = 22) or (B) AstraZeneca AZD AZD1222 (n = 41). (C–E) Serum from volunteers suffering vaccine breakthrough BA.1 (n = 16), BA.2 (n = 23), or BA.4/5 (n = 11) infections. (F) IC50 values for single RBD point mutations inserted into the BA.2 pseudovirus using Pfizer BNT162b2 serum (n = 22). Geometric mean titers are shown above each column. The Wilcoxon matched-pairs signed rank test was used for the analysis and two-tailed p values were calculated. See also Table S3 .
Article Snippet: To understand the effects of the individual mutations in the BA.2.75 RBD, we introduced them individually into the pseudovirus BA.2 background and assayed their neutralization using triple-vaccinated Pfizer BNT162b2 serum ( F).
Techniques: Neutralization, Two Tailed Test